
Sign up to save your podcasts
Or


In this episode of CTSNet’s flagship podcast, editor in chief Joel Dunning interviews Dr. Michael Mack. Dr. Mack, of Baylor Healthcare System, is the first author of the PARTNER 3 trial, which recently published its five-year results. They talk about the outcomes of the trial and what they mean for the future of TAVR.
Items Mentioned
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
By CTSNet4.6
88 ratings
In this episode of CTSNet’s flagship podcast, editor in chief Joel Dunning interviews Dr. Michael Mack. Dr. Mack, of Baylor Healthcare System, is the first author of the PARTNER 3 trial, which recently published its five-year results. They talk about the outcomes of the trial and what they mean for the future of TAVR.
Items Mentioned
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

91,267 Listeners

43,837 Listeners

133 Listeners

502 Listeners

1,304 Listeners

901 Listeners

1,469 Listeners

2,462 Listeners

113,446 Listeners

30 Listeners

8,010 Listeners

90 Listeners

441 Listeners

29,232 Listeners

4 Listeners